Researchers at the University of Barcelona found that combining pemafibrate and telmisartan significantly reduces liver fat and cardiovascular risks in MASLD models. The drug duo works better together ...

Scientists in Barcelona have identified a potential new treatment for metabolic liver conditions by repurposing pemafibrate ...

High blood pressure, or hypertension, is a common condition especially among older adults. If not managed properly, it can quietly increase the risk of heart attacks, strokes, and kidney problems.

Using a rat model and zebrafish larvae, the team evaluated the drugs' ability to reduce liver fat accumulation. The study ...